Powered by

Indivior to Divest Interest in China

Feb 04, 2019 - Targeted News Service
Mergers and Acquisitions

Indivior, a pharmaceutical company, issued the following news release:

Slough, UK and Richmond, VA - Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that it has entered into a definitive agreement to divest its rights related to the Sai Bo Song(TM) (buprenorphine, naloxone) tablet in China to Zhejiang Pukang Biotechnology Co., Ltd. ("Pukang") for a total consideration of up to $122.5 million.

Pukang is a privately held company focused on vaccines and headquarte...